Who invested in Epsilogen?
2 investors are on record as having backed Epsilogen — World leader in IgE drugs for solid cancer tumors, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
epsilogen.comEpsilogen investors
ALSA VenturesBacks biotech companies developing novel therapeutics, leveraging deep industry…their site
UCL Technology FundBacks deep tech ventures from UCL research, offering early capital and hands-on support.their site
No round dates are on record for Epsilogen. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Epsilogen are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.